Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) traded at $12.33 at close of the session on Tuesday, July 15 and made an upward move of 272.51% on its previous day’s price.
Looking at the stock we see that its previous close was $3.31 and the beta (5Y monthly) reads 0.247 with the day’s price range being $4.55 – $19.24. In terms of its 52-week price range, CYCC has a high of $597.60 and a low of $3.08. The company’s stock has gained about 128.97% over that past 30 days.
Cyclacel Pharmaceuticals Inc has a market cap of $19.52 million and is expected to release its quarterly earnings report on 2025-Apr-02. With its Forward Dividend at 36.00 and a yield of 291.97%, the company’s investors could be anxious for the CYCC stock to gain ahead of the earnings release.
On the other hand, looking at the outlook for the CYCC stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Cyclacel Pharmaceuticals Inc (CYCC) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 151.97% off its SMA20 and -41.34% from its 50-day simple moving average. The RSI (14) is pointing at 57.15 while the volatility over the past week is 78.30% and jumps to 31.71% over the past one month. The average price target for the stock over the next 12 months is $1, with the estimates having a low of $1 and a high of $1. These price ends are 91.89% and 91.89% off the current price level respectively, although investors could be excited at the prospect of a 91.89% if the CYCC share price touches on the median price of $1.
Coming back to Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC), we note that the average 3-month trading volume was 210.26K, while that of the preceding 10-day period stands at 0.68 million. Current shares outstanding are 1.58 million.
The insiders hold 0.00% of the company’s shares while institutions hold 0.43%. The data shows that short shares as of 2025-06-13, stood at 0.6 million at a short ratio of 0.26. This represents a 8168.00 short interest in shares outstanding on 2025-06-13. Shares short rose in June from the previous month at 30021.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -96.66% down in year-to-date price movement.
